CXCR4+ haematological and solid tumour cells co-opt the role of CXCL12/CXCR4 in development and the “homing” of cancer cells to bone marrow is associated with therapy resistance and poor prognosis20,21. This evidence concerns the gene CXCR4 and cancer.